Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Exploring the Implications of Small-Area Variation in the Incidence of Multiple Sclerosis.
The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial.
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.
Fluctuations of spontaneous EEG topographies predict disease state in relapsing-remitting multiple sclerosis.
Port-to-port delivery: Mobilization of toxic sphingolipids via extracellular vesicles.
Estimating epidemiological data of Multiple sclerosis using hospitalized data in Shandong Province, China.
Development and feasibility of the Help to Overcome Problems Effectively (HOPE) self-management intervention for people living with multiple sclerosis.
Pathophysiological Concepts in Multiple Sclerosis and the Therapeutic Effects of Hydrogen Sulfide.
RAGE-ligand axis: A new biomarker in multiple sclerosis, time for multicentre validation study!
Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats.
NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.
Regulation of PERK-eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytes.
Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.
Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.
Protandim Protects Oligodendrocytes against an Oxidative Insult.
"Gadolinium-Phobia:" Not a Helpful "Criterion" for Indication for Gadolinium-based Contrast Agent Administration in Multiple Sclerosis.
Engineering Biomaterials to Influence Oligodendroglial Growth, Maturation, and Myelin Production.
Yellow fever vaccine-associated neurotropic disease (YEL-AND) - A case report.
Determinants of stigma in a cohort of hellenic patients suffering from multiple sclerosis: a cross-sectional study.
Involvement of the optic nerve in mutated CSF1R-induced hereditary diffuse leukoencephalopathy with axonal spheroids.
Qualitative exploration of the benefits of group-based memory rehabilitation for people with neurological disabilities: implications for rehabilitation delivery and evaluation.
Pathophysiology, assessment and management of multiple sclerosis fatigue: an update.
Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.
Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.
Pages
« first
‹ previous
…
840
841
842
843
844
845
846
847
848
…
next ›
last »